A Comparative Review of mRNA, Viral Vector, Inactivated, and Protein Subunit COVID-19 Vaccines
International Journal of Community Pharmacy · 30.06.2025 · 29-38
DOI: 10.65301/ijcp.2025.6.2.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Community Pharmacy, online erschienen am 30.06.2025. Verfasst von Ghode Payal und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The COVID-19 pandemic prompted an unprecedented global response in vaccine development. Multiple platforms, including mRNA,viral vector, inactivated, and protein subunit vaccines, were rapidly developed to curb the spread of SARS-CoV-2. This review provides a comparative analysis of these vaccine types, focusing on their mechanisms of action, efficacy, safety profiles, storage requirements, and global distribution. mRNA vaccines such as PfizerBioN Tech and Modern a demonstrated high efficacy, while viral vector vaccines like AstraZeneca and Johnson & Johnson offered logistical advantages. Inactivated vaccines such as Covaxin and Sinopharm are based on traditional methods and showed good safety profiles. Protein subunit vaccines like Novavax are emerging as a promising alternative with minimal side effects. Understanding these differences is essential for informed public health decisions, vaccine acceptance, and future pandemic preparedness.
Zitieren
APA
Payal, G., Vaishnavi, J., & Sunil, R. (2025). A Comparative Review of mRNA, Viral Vector, Inactivated, and Protein Subunit COVID-19 Vaccines. International Journal of Community Pharmacy, 29-38. https://doi.org/10.65301/ijcp.2025.6.2.5
Vancouver
Payal G, Vaishnavi J, Sunil R. A Comparative Review of mRNA, Viral Vector, Inactivated, and Protein Subunit COVID-19 Vaccines. International Journal of Community Pharmacy. 2025:29-38. doi:10.65301/ijcp.2025.6.2.5
BibTeX
@article{Payal2025,
author = {Payal, Ghode and Vaishnavi, Jambhulkar and Sunil, Rathod},
title = {A Comparative Review of mRNA, Viral Vector, Inactivated, and Protein Subunit COVID-19 Vaccines},
journal = {International Journal of Community Pharmacy},
year = {2025},
pages = {29--38},
doi = {10.65301/ijcp.2025.6.2.5}
}
EUVIMED